Qingdao Baheal Medical, INC.

Qingdao Baheal Medical, INC. experienced notable trading activity, reaching an intraday high of CNY 20.36. However, the company's longer-term performance shows a decline, with a 29.5% drop in profits over the past year and a three-year performance decrease of 27.59%.

Qingdao Baheal Medical, INC. has faced significant stock price declines, with a notable drop today and a decrease over the past week and month. The company has struggled with negative performance metrics for six consecutive quarters, highlighting ongoing challenges in growth and financial stability amid a contrasting market environment.

Qingdao Baheal Medical, a key player in the Pharmaceuticals & Biotechnology sector, experienced notable trading activity on May 22, 2026. While the stock has shown strong annual performance, it faces challenges with declining short-term metrics and ongoing operational hurdles, including six consecutive quarters of negative results.

Qingdao Baheal Medical, INC. saw a significant stock price drop today, contrasting with the broader market's decline. Despite a slight weekly increase, the company has faced challenges, including a notable net profit decline in the first half of the year and ongoing pressures reflected in its financial metrics.

Qingdao Baheal Medical, INC. has faced significant stock price declines, with a 5.26% drop today and a 14.49% decrease year-to-date. Financial metrics reveal a 34.66% decline in net profit for the first half of the year, highlighting ongoing challenges in the company's performance.

Qingdao Baheal Medical, a significant player in the Pharmaceuticals & Biotechnology sector, has faced a stock price decline amid financial challenges. The company reported a 34.66% drop in net profit for the first half of the year and modest growth in net sales and operating profit, indicating a tough market environment.